Intradigm Corp. merger with Silence Therapeutics plc
|
|
|
|
|
discovery. development and delivery of targeted; systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases with an initial focus on oncology | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|